Evidence map›Paper›PMID 37644600›Full record

ArticleEuropean journal of medical research2023

The role of cortisol in immunosuppression in subarachnoid haemorrhage.

Margaret E Hoadley, James Galea, Navneet Singh, Sharon Hulme, David O Ajao, Nancy Rothwell, Andrew King, Pippa Tyrrell, Stephen J Hopkins

Open access · goldAbstract read
In one paragraph

Article in European journal of medical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Margaret E HoadleyNorthern Care Alliance Research and Innovation, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK. margaret.hoadley@manchester.ac.uk.
James GaleaNinewells Hospital and Medical School, University of Dundee, Ninewells, Dundee, DD1 9SY, UK.
Navneet SinghAtkinson Morley, Dept of Neurosurgery, St Georges Hospital, Blackshaw Rd, London, Sw17 0QT, UK.
Sharon HulmeDivision of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Stott Lane, Salford, M13 9PT, UK.
David O AjaoDivision of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Stott Lane, Salford, M13 9PT, UK.
Nancy RothwellFaculty of Life Sciences, University of Manchester, AV Hill Building, Oxford Road, Manchester, M13 9PL, UK.
Andrew KingDivision of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Stott Lane, Salford, M13 9PT, UK.
Pippa TyrrellDivision of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Stott Lane, Salford, M13 9PT, UK.
Stephen J HopkinsNorthern Care Alliance Research and Innovation, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK.
Manchester Academic Health Science Centre · GBUniversity of Manchester · GBSalford Royal NHS Foundation Trust · GBSt George's Hospital · GB

Funding

Medical Research Council G0502030Medical Research Council G0502030 ID: 77198Medical Research Council G1001252: 700,000
6 · The paper itself

Abstract

backgroundWe sought to determine the extent to which cortisol suppressed innate and T cell-mediated cytokine production and whether it could be involved in reducing peripheral cytokine production following subarachnoid haemorrhage (SAH).

methodsWhole blood from healthy controls, patients with SAH and healthy volunteers was stimulated with lipopolysaccharide (LPS), to stimulate innate immunity, or phytohaemagglutinin (PHA), to stimulate T cell-mediated immunity. Varying concentrations of cortisol were included, with or without the cortisol antagonist RU486. Concentration of interleukin-6 (IL-6), IL-1β and tumour necrosis factor-alpha) TNFα were determined as a measure of innate immunity. IL-6, IL-17 (interferon gamma) IFNƔ and IL-17 were determined as an indicator of T cell-mediated immunity.

resultsSuppression of innate responses to LPS was apparent in whole blood from SAH patients, relative to healthy controls, and TNFα production was inversely correlated with plasma cortisol concentration. Cytokine production in whole blood from healthy volunteers was inhibited by cortisol concentrations from 0.33 µM, or 1 µM and above, and these responses were effectively reversed by the cortisol antagonist RU-486. In SAH patients, RU-486 reversed suppression of innate TNF-α and IL-6 responses, but not IL-1ß or T cell-mediated responses.

conclusionThese data suggest that cortisol may play a role in reducing innate, but not T cell-mediated immune responses in patients with injuries such as SAH and that cortisol antagonists could be effective in boosting early innate responses.

Indexed as

HydrocortisoneSubarachnoid HemorrhageHumansImmunosuppression TherapyInterferon-gammaInterleukin-17Interleukin-6LipopolysaccharidesMifepristoneTumor Necrosis Factor-alphaHydrocortisoneInterferon-gammaInterleukin-17Interleukin-6LipopolysaccharidesMifepristoneTumor Necrosis Factor-alphaCortisolCytokinesImmune responseImmunosuppressionInfectionRU-486

Identifiers

PMID37644600
PMCPMC10466816
OpenAlexW4386261777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.